Second Sight Medical Stock Revenue
EYESDelisted Stock | USD 4.14 0.20 4.61% |
Second Sight Medical fundamentals help investors to digest information that contributes to Second Sight's financial success or failures. It also enables traders to predict the movement of Second Stock. The fundamental analysis module provides a way to measure Second Sight's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Second Sight stock.
Second |
Second Sight Medical Company Revenue Analysis
Second Sight's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Second Sight Revenue | 497 K |
Most of Second Sight's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Second Sight Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
CompetitionBased on the latest financial disclosure, Second Sight Medical reported 497 K of revenue. This is 99.99% lower than that of the Healthcare sector and 99.98% lower than that of the Medical Devices industry. The revenue for all United States stocks is 99.99% higher than that of the company.
Second Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Second Sight's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Second Sight could also be used in its relative valuation, which is a method of valuing Second Sight by comparing valuation metrics of similar companies.Second Sight is currently under evaluation in revenue category among related companies.
Second Fundamentals
Return On Equity | -19.02 | |||
Return On Asset | -10.74 | |||
Current Valuation | 11.54 M | |||
Shares Outstanding | 39.41 M | |||
Shares Owned By Insiders | 28.61 % | |||
Shares Owned By Institutions | 7.01 % | |||
Number Of Shares Shorted | 1.19 M | |||
Price To Earning | (1.61) X | |||
Price To Book | 0.93 X | |||
Price To Sales | 616.54 X | |||
Revenue | 497 K | |||
Gross Profit | 130 K | |||
EBITDA | (8.24 M) | |||
Net Income | (8.29 M) | |||
Cash And Equivalents | 59.6 M | |||
Cash Per Share | 1.51 X | |||
Total Debt | 199 K | |||
Debt To Equity | 0 % | |||
Current Ratio | 25.25 X | |||
Book Value Per Share | (0.03) X | |||
Cash Flow From Operations | (10.38 M) | |||
Short Ratio | 7.36 X | |||
Earnings Per Share | (0.72) X | |||
Number Of Employees | 15 | |||
Beta | 2.76 | |||
Market Capitalization | 163.15 M | |||
Total Asset | 28.25 M | |||
Retained Earnings | (328.85 M) | |||
Working Capital | 18.78 M | |||
Current Asset | 26.76 M | |||
Current Liabilities | 7.98 M |
About Second Sight Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Second Sight Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Second Sight using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Second Sight Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Second Sight
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Second Sight position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Second Sight will appreciate offsetting losses from the drop in the long position's value.Moving together with Second Stock
0.74 | MDT | Medtronic PLC Financial Report 23rd of May 2024 | PairCorr |
Moving against Second Stock
0.63 | BSX | Boston Scientific Corp Earnings Call Today | PairCorr |
0.53 | EW | Edwards Lifesciences Corp Earnings Call Tomorrow | PairCorr |
0.5 | DXCM | DexCom Inc Earnings Call Tomorrow | PairCorr |
0.5 | ALGN | Align Technology Earnings Call Today | PairCorr |
0.45 | LRDG | Lord Global Corp | PairCorr |
The ability to find closely correlated positions to Second Sight could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Second Sight when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Second Sight - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Second Sight Medical to buy it.
The correlation of Second Sight is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Second Sight moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Second Sight Medical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Second Sight can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. Note that the Second Sight Medical information on this page should be used as a complementary analysis to other Second Sight's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Consideration for investing in Second Stock
If you are still planning to invest in Second Sight Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Second Sight's history and understand the potential risks before investing.
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Transaction History View history of all your transactions and understand their impact on performance | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |